Beverly Langford

Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial

Sanjay Ramakrishnan, Dan V. Nicolau, Beverly Langford et al. · The Lancet Respiratory Medicine · 2021 · 427 citations · Full text

Early Covid-19, Respiratory Diseases, Respiratory Infection +6

Sleep Fragmentation Indices as Predictors of Daytime Sleepiness and nCPAP Response in Obstructive Sleep Apnea

L S Bennett, Beverly Langford, John Stradling et al. · American Journal of Respiratory and Critical Care Medicine · 1998 · 189 citations

Exhaled nitric oxide as a screening tool for asthma in school children

Anjani Prasad, Beverly Langford, John Stradling et al. · Respiratory Medicine · 2005 · 61 citations · Full text

Asthma, Allergy, Pediatrics +5

Inhaled budesonide in the treatment of early COVID-19 illness: a randomised controlled trial

Sanjay Ramakrishnan, Dan V. Nicolau, Beverly Langford et al. · 2021 · 25 citations · Full text

Inhaled Budesonide, Long Covid, Early Covid-19 Illness +14